Drug did not extend lives

Drug did not extend lives
WASHINGTON – US GOVERNMENT health scientists said on Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential withdrawal in that indication. The Food and Drug Administration approved Roche’s blockbuster Avastin in 2008 based on early-stage trials showing it shrank tumors caused by breast cancer. The …

Read more on Straits Times